Dr. Ndu is the Chief Regulatory Officer for BridgeBio Pharma Inc. Prior to joining BridgeBio, Dr. Ndu served as Group Vice President, Worldwide Research & Development, Strategy, Scientific Collaborations and Policy at BioMarin Pharmaceutical, Inc. She has over 15 years of experience in drug development and regulatory affairs in U.S. and international markets. Dr. Ndu was formerly Director and Head of the Division of Medical Policy Development at the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research and also a Commander in the Commissioned Corps, U.S. Public Health Service. She has been involved in the registrations of multiple products globally and is a respected thought leader in regulatory science, having played a significant role in developing and evaluating guidance, as well as shaping regulatory policy. Dr. Ndu received her doctorate in pharmacy from Howard University’s College of Pharmacy and a law degree from the University of Maryland; she completed a residency at Georgetown University Hospital and a fellowship at Procter & Gamble Pharmaceuticals. She currently serves on the Board of Directors for Acadia Pharmaceuticals (ACAD) and DBV Technologies (DBVT), as well as a number of non-profit organizations.